Rural Veteran and Care Partner Walking Program
Remotely Improving Physical Activity in Rural Veterans With Cognitive Impairment and Care Partner Dyads
The purpose of this study is to determine the practicality/feasibility of a virtual physical activity intervention to improve daily steps for Veterans with mild cognitive impairment and their care partners living in rural areas.
Participation includes:
- Complete a 6-week walking program
- Complete 2 testing visits (1 before and 1 after the 6-week walking program) consisting of various surveys and questionnaires
- Complete a semi-structured interview on feasibility and feedback of the intervention
- Potentially serve on an advisory board with the research team to assist with implementing the walking program adaptations
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Rashelle Hoffman, PT, DPT, PhD
- Número de telefone: 402-280-5691
- E-mail: rashellehoffman@creighton.edu
Locais de estudo
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68178
- Recrutamento
- Creighton University
-
Contato:
- Rashelle Hoffman, PT, DPT, PhD
- Número de telefone: 402-280-5691
- E-mail: rashellehoffman@creighton.edu
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria for Veterans:
- 60-95 years of age
- Mild cognitive impairment as staged by Clinical Dementia Rating (CDR, a gold standard cognitive outcome in ADRD clinical research) score of 0.5 or equivalent
- Characterized as underactive by the Telephone Assessment of Physical Activity (TAPA)
- Have a care partner willing to participate in physical activity and assist the participant
- Own a smartphone or tablet and willing to download a fitness tracker application
- Live in a rural area according to the VA Office of Rural Health rurality calculator
Inclusion Criteria for Veterans & Care Providers:
- No self-reported falls in the last year
- Able to walk across a room in the home with no assistive device(s)
- Stable doses of medication over the previous 30 days
- Pass the Physical Activity Readiness Questionnaire+ (answering "no" to questions are pages 1-3)
- Interaction as a dyad (Veteran and care partner) at least on a weekly basis
Inclusion Criteria for Veterans & Care Providers:
- 19 years of age or older
- No cognitive impairment as indicated by a score of < 1 on the AD8 Dementia Screening Interview
Exclusion Criteria for Veterans & Care Providers:
- Neurodegenerative or acute neurological diagnoses (e.g., Parkinson's disease, stroke, traumatic brain injury)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Field Testing Group
|
Six dyads (n=12) will complete TPAB field testing and will undergo testing at baseline and post-intervention. Consent, baseline testing, intervention delivery, and post-testing will be conducted virtually via Microsoft Teams and data recorded in VA REDCap. Testing sessions will not be recorded, with the exception of semi-structured interviews during post-testing. The testing procedures will take approximately 2 hours to complete at each testing time point. The TPAB intervention will involve weekly 30-minute sessions with study personnel for 6 weeks. Due to the 7-day activity monitor data collection prior to and following the 6-week TPAB intervention, participants will be enrolled in the study for approximately 8 weeks. Three dyads will be asked to join the advisory board with the research team to assist with implementing the walking program adaptations based on the collective feedback across the 16 dyads. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Weekly Session Attendance
Prazo: From enrollment to end of the 6-week intervention
|
The total number of sessions attended by dyads will be reported as a percentage of the 6 weekly sessions. Ranges of attendance could be 0% (not attending any sessions) to 100% attending all session. Attendance will be used to evaluate participant engagement and practicality of implementation. |
From enrollment to end of the 6-week intervention
|
|
Study Retention
Prazo: From enrollment to end of intervention at 8 weeks
|
Defined as continued participation through the study completion. Calculated using withdrawal and completion records. Higher retention (such as 100% retention indicating all dyads that enrolled in the study, completed the study) supports intervention feasibility. |
From enrollment to end of intervention at 8 weeks
|
|
Intrinsic Motivation Inventory (IMI)
Prazo: Post-intervention (week 8)
|
Evaluates participant interest, enjoyment, perceived value, and engagement with the intervention. The IMI is comprised of 7 statements related to interest/enjoyment that the participant indicates how true the statement is to them regarding their experience participating in the intervention. Each statement is scored on a 1-7 scale and an average is computed across all the questions to determine the IMI score. Higher scores indicate greater intervention acceptability. |
Post-intervention (week 8)
|
|
Number of participants with study-related adverse events
Prazo: From enrollment to end of intervention at 8 weeks
|
Includes falls, injuries, medical issues, skin irritation, or other unintended consequences. Used to evaluate intervention safety. |
From enrollment to end of intervention at 8 weeks
|
|
Average Daily Stepping
Prazo: Pre (before starting the 6-week walking program) and Post Intervention (following completion of the 6-week walking program)
|
Objective measure of physical activity captured through Fitbit devices. Average daily step counts are computed in the Fitbit application and will be recorded for each day and averaged over the 7-day monitoring period before and after the intervention provide proof-of-concept evidence of behavior change. |
Pre (before starting the 6-week walking program) and Post Intervention (following completion of the 6-week walking program)
|
|
Qualitative Intervention Feasibility Outcomes
Prazo: Post-intervention (for feedback)
|
Interviews evaluating demand, implementation, practicality, acceptability, adaptation, and integration. Findings will guide refinement of the intervention for future trials. |
Post-intervention (for feedback)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Creighton IRB: 2005570
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .